Digital cell biology company Berkeley Lights of Emeryville, California, on Monday filed for an initial public offering worth up to $153.2 million.
In a filing with the US Securities and Exchange Commission, the firm said it is offering 7.4 million shares of common stock at an estimated price of $16 to $18 per share. Berkeley Lights has also granted the underwriters a 30-day option to purchase up to 1,110,000 additional shares of common stock at the IPO price.
The company has applied to list its stock on the Global Market under the trading symbol BLI.
In 2018, Berkeley Lights raised $95 million in a financing round and struck a collaboration deal with Pfizer. The company has developed a platform, based on opto-electropositioning (OEP) fluidics technology, to capture phenotypic, functional, and genotypic information from thousands of single cells in parallel.